Your browser doesn't support javascript.
loading
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
Kobayashi, Kazuo; Toyoda, Masao; Hatori, Nobuo; Sakai, Hiroyuki; Furuki, Takayuki; Chin, Keiichi; Kimura, Moritsugu; Saito, Nobumichi; Kanaoka, Tomohiko; Aoyama, Togo; Umezono, Tomoya; Ito, Shun; Suzuki, Daisuke; Takeda, Hiroshi; Minagawa, Fuyuki; Degawa, Hisakazu; Machimura, Hideo; Hishiki, Toshimasa; Umezawa, Shinichi; Shimura, Hidetoshi; Nakajima, Shinichi; Yamamoto, Hareaki; Sato, Kazuyoshi; Miyakawa, Masaaki; Terauchi, Yasuo; Tamura, Kouichi; Kanamori, Akira.
Afiliação
  • Kobayashi K; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Electronic address: k-taishi@xc4.so-net.ne.jp.
  • Toyoda M; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, lsehara, Japan.
  • Hatori N; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Sakai H; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Furuki T; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Chin K; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Kimura M; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, lsehara, Japan.
  • Saito N; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, lsehara, Japan.
  • Kanaoka T; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Aoyama T; Division of Nephrology, Department of internal medicine, Kitasato University School of Medicine, Sagamihara, Japan.
  • Umezono T; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Ito S; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Suzuki D; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Takeda H; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Minagawa F; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Degawa H; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Machimura H; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Hishiki T; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Umezawa S; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Shimura H; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Nakajima S; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Yamamoto H; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Sato K; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Miyakawa M; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Terauchi Y; Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Tamura K; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kanamori A; Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
Diabetes Res Clin Pract ; 185: 109231, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35131376
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simportadores / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Diabetes Res Clin Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de publicação: Irlanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simportadores / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Diabetes Res Clin Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de publicação: Irlanda